Amino Acids 6: 1523
A weekly, one-milligram injection of semaglutide, the active ingredient in Ozempic and the weight loss drug Wegovy, was found to reduce the combined risk of major kidney complications (including kidney failure), cardiovascular events, and even death from any cause by 24% in patients with type 2 diabetes and chronic kidney disease, according to a study published in May in The New England Journal of Medicine
12 Summary This review summarizes current knowledge on the effects of KD on the skin, particularly its potential therapeutic role in inflammatory skin diseases, such as acne vulgaris, psoriasis, hidradenitis suppurativa, and skin cancer
Across the Phase 2 and Phase 3 trials, heart rate increased by approximately 6.7 bpm at the 12 mg dose, peaking around week 24 and declining thereafter
Yet even these strategies face limitations in terms of delivery specificity, metabolic variability among patients, and potential off-target effects